Bausch Health
332 hedge funds and large institutions have $5.04B invested in Bausch Health in 2019 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 96 increasing their positions, 112 reducing their positions, and 59 closing their positions.
8% more funds holding in top 10
Funds holding in top 10: 13 → 14 (+1)
6% more capital invested
Capital invested by funds: $4.76B → $5.04B (+$279M)
2.57% more ownership
Funds ownership: 54.76% → 57.33% (+2.6%)
5% less funds holding
Funds holding: 349 → 332 (-17)
14% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 112
18% less call options, than puts
Call options by funds: $393M | Put options by funds: $479M
20% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 59
Top Buyers
Top Sellers
BHC Hedge Fund Activity: Q2 2019 in Review
332 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2019, worth a combined $5.04B — up 5.9% from $4.76B a quarter earlier.
Sellers outnumbered buyers: 59 funds closed out of BHC and 47 opened new positions — a net loss of 12 holders — while 112 trimmed existing stakes and 96 added.
The largest buyer was Fidelity International, adding an estimated $342M. The largest seller was Nomura Holdings, cutting an estimated $82.8M.
- 332 institutional investors held Bausch Health (BHC) as of Q2 2019, down from 349 in Q1 2019.
- Funds reported $5.04B of Bausch Health stock for Q2 2019, up 5.9% quarter-over-quarter.
- 47 funds opened new Bausch Health positions in Q2 2019 and 59 closed out, a net change of -12 holders.
- The largest Bausch Health buyer in Q2 2019 was Fidelity International, an estimated $342M added.
- The largest Bausch Health seller in Q2 2019 was Nomura Holdings, an estimated $82.8M sold.
Based on aggregated 13F filings for Q2 2019.